Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BQY
|
|||
| Former ID |
DNC010587
|
|||
| Drug Name |
(E)-N-(6-(prop-1-enyl)-1H-indazol-3-yl)butyramide
|
|||
| Synonyms |
CHEMBL1086176; (E)-N-(6-(prop-1-enyl)-1H-indazol-3-yl)butyramide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H17N3O
|
|||
| Canonical SMILES |
CCCC(=O)NC1=NNC2=C1C=CC(=C2)C=CC
|
|||
| InChI |
1S/C14H17N3O/c1-3-5-10-7-8-11-12(9-10)16-17-14(11)15-13(18)6-4-2/h3,5,7-9H,4,6H2,1-2H3,(H2,15,16,17,18)/b5-3+
|
|||
| InChIKey |
KPYYGELCJSEEPK-HWKANZROSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1985-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.